We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-2.5%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$333B
AUM Growth
-$5.65B
Cap. Flow
+$10.7B
Cap. Flow %
3.22%
Top 10 Hldgs %
17.75%
Holding
3,695
New
106
Increased
2,783
Reduced
461
Closed
115

Top Buys

Rank Stock Value
1
EOG icon
EOG Resources
EOG
+$727M
2
HD icon
Home Depot
HD
+$472M
3
PFE icon
Pfizer
PFE
+$362M
4
TXN icon
Texas Instruments
TXN
+$314M
5
LYB icon
LyondellBasell Industries
LYB
+$299M

Sector Composition

Rank Sector Weight
1 Technology 21.07%
2 Financials 12.97%
3 Healthcare 12.01%
4 Consumer Discretionary 10.22%
5 Industrials 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWCZ
2826
DELISTED
European Wax Center
EWCZ
$1.06M ﹤0.01%
35,868
+1,116
+3% +$29K
VRA icon
2827
Vera Bradley
VRA
$99.5M
$1.06M ﹤0.01%
138,127
+70,361
+104% +$556K
PRDS
2828
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$1.06M ﹤0.01%
+146,804
New +$1.44M
OPY icon
2829
Oppenheimer Holdings
OPY
$1.27B
$1.06M ﹤0.01%
24,224
-25,053
-51% -$1.1M
AMNB
2830
DELISTED
American National Bankshares Inc
AMNB
$1.05M ﹤0.01%
27,863
-3,060
-10% -$117K
LXRX icon
2831
Lexicon Pharmaceuticals
LXRX
$1.07B
$1.05M ﹤0.01%
501,128
+12,710
+3% +$35.2K
CTT
2832
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$1.05M ﹤0.01%
127,683
+3,584
+3% +$29.4K
ESTE
2833
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$1.04M ﹤0.01%
82,690
+12,506
+18% +$163K
BKKT icon
2834
Bakkt Inc
BKKT
$338M
$1.04M ﹤0.01%
6,724
+871
+15% +$124K
INBK icon
2835
First Internet Bancorp
INBK
$254M
$1.04M ﹤0.01%
24,078
+165
+0.7% +$7.99K
DAWN
2836
DELISTED
Day One Biopharmaceuticals
DAWN
$1.03M ﹤0.01%
104,034
+27,866
+37% +$368K
CTO
2837
CTO Realty Growth
CTO
$815M
$1.03M ﹤0.01%
46,608
FPI
2838
Farmland Partners
FPI
$421M
$1.03M ﹤0.01%
74,790
+2,655
+4% +$32.2K
RMO
2839
DELISTED
Romeo Power, Inc.
RMO
$1.02M ﹤0.01%
681,839
-50,068
-7% -$105K
BYRN icon
2840
Byrna Technologies
BYRN
$111M
$1.01M ﹤0.01%
123,221
+3,885
+3% +$39.5K
BLFY
2841
DELISTED
Blue Foundry Bancorp
BLFY
$1.01M ﹤0.01%
74,224
+1,956
+3% +$27.6K
SMBC icon
2842
Southern Missouri Bancorp
SMBC
$875M
$1.01M ﹤0.01%
20,131
+695
+4% +$36.9K
TRUE
2843
DELISTED
TrueCar
TRUE
$1.01M ﹤0.01%
254,478
+9,534
+4% +$33.7K
FNA
2844
DELISTED
Paragon 28, Inc.
FNA
$1M ﹤0.01%
59,922
+5,393
+10% +$86.8K
EBTC
2845
DELISTED
Enterprise Bancorp
EBTC
$1M ﹤0.01%
24,995
VTYX
2846
DELISTED
Ventyx Biosciences
VTYX
$1M ﹤0.01%
73,803
+2,482
+3% +$33.2K
MPB icon
2847
Mid Penn Bancorp
MPB
$978M
$998K ﹤0.01%
37,208
+973
+3% +$28.2K
OCUL icon
2848
Ocular Therapeutix
OCUL
$1.9B
$996K ﹤0.01%
201,067
+7,974
+4% +$44.2K
FTCI icon
2849
FTC Solar
FTCI
$49.3M
$992K ﹤0.01%
20,110
+6,435
+47% +$322K
HGEN
2850
DELISTED
HUMANIGEN, INC.
HGEN
$991K ﹤0.01%
329,031
-13,879
-4% -$37.1K

Similar funds

Charles Schwab's Q1 2022 Portfolio in Review

As of Q1 2022, Charles Schwab held 3,695 positions worth $333B, down 1.7% from $339B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Charles Schwab deployed $10.7B of net new capital in Q1 2022, opening 106 new positions and adding to 2,783 existing holdings. Its largest new stake was Constellation Energy: 1,449,939 shares worth $81.6M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Emerson Electric, an estimated $567M trimmed.

  • Charles Schwab's largest Q1 2022 buy was Constellation Energy: 1,449,939 shares worth $81.6M.
  • Charles Schwab added most to EOG Resources in Q1 2022, an estimated $727M increase.
  • Charles Schwab's biggest Q1 2022 reduction was Emerson Electric, cutting an estimated $567M.
  • Charles Schwab fully exited Xilinx Inc in Q1 2022, selling an estimated $245M.
  • Charles Schwab's ten largest holdings make up 18% of its $333B portfolio in Q1 2022.
  • Charles Schwab opened 106 new positions and closed 115 in Q1 2022.
  • Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $333B.

Based on Charles Schwab's 13F filing for Q1 2022, filed 13 May 2022.